TOMI Environmental Solutions Disrupts the Dairy Industry with Major Mexican Dairy Brand
Rigorous Pathogen Testing and Proven Preservation Results Drive SteraMist Adoption at Major Mexican Dairy FacilityFREDERICK, Md., March 24, 2026 (GLOBE...
Rigorous Pathogen Testing and Proven Preservation Results Drive SteraMist Adoption at Major Mexican Dairy FacilityFREDERICK, Md., March 24, 2026 (GLOBE...
Being Published in the Journal of Vascular and Interventional Radiology, a Premier Peer-Reviewed Journal, Speaks to the Quality and Impact...
$21 Million debt financing, convertible to ENLV ordinary shares at fixed $2.69175 per share, a 264% premium to the Nasdaq...
NASHVILLE, Tenn., March 24, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America,...
Premier 714-bed teaching hospital and Level I Trauma Center purchases ENvue™ Navigation Platform system and feeding tubesTYLER, Texas, March 24,...
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show differential linker...
Partnerships Expand Access to Advanced Neurological and Psychiatric Care in Florida and AlabamaBATON ROUGE, La., March 24, 2026 (GLOBE NEWSWIRE)...
PRESS RELEASE - 03/24/2026, 08:00 EDT Biocartis to Collaborate with Medical College of Wisconsin on Breast Cancer Gene Signatures Itasca,...
Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge...
LAWRENCEVILLE, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with...
Additional analyses from the SCORED and SOTA-P-CARDIA studies provide further evidence of benefits across patient subgroups potentially related to sotagliflozin's...
AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”),...
RADNOR, Pa., March 24, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines...
Strategic partnership to ensure delivery of scalable, cost-effective, and reliable plasmid sequencing as Addgene’s repository expandsWATERTOWN, Mass. and SAN FRANCISCO,...
Callio Therapeutics is actively developing a pipeline of promising dual-payload ADCs featuring rationally designed payload combinations for hard-to-treat tumors CLIO-8221...
Applied StemCell and Cellipont Bioservices Partner Together Applied StemCell and Cellipont Bioservices partner together to streamline and accelerate the development...
Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 24, 2026...
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology...
-- Dr. Ashworth Brings Decades of Scientific and Clinical Experience Translating Synthetic Lethality Discoveries into Precision Cancer Therapies -- SOUTH...
Launched VIZZ® (aceclidine ophthalmic solution) 1.44% for the treatment of presbyopia in October 2025 and generated net product revenues of...